Skip to main content
Top
Literature
1.
go back to reference Marti C, John G, Konstantinides S, Combescure C, Sanchez O, Lankeit M, Meyer G, Perrier A (2015) Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J 36:605–614CrossRefPubMed Marti C, John G, Konstantinides S, Combescure C, Sanchez O, Lankeit M, Meyer G, Perrier A (2015) Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J 36:605–614CrossRefPubMed
2.
go back to reference Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JS, Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) et al (2014) ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur. Heart J 35:3033–3069CrossRefPubMed Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JS, Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) et al (2014) ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur. Heart J 35:3033–3069CrossRefPubMed
3.
go back to reference Kearon C, Ak EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H et al (2016) Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 149:315–352CrossRefPubMed Kearon C, Ak EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H et al (2016) Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 149:315–352CrossRefPubMed
4.
go back to reference Daniels LB, Parker JA, Patel SR, Grodstein F, Goldhaber SZ (1997) Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism. Am J Cardiol 80:184–188CrossRefPubMed Daniels LB, Parker JA, Patel SR, Grodstein F, Goldhaber SZ (1997) Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism. Am J Cardiol 80:184–188CrossRefPubMed
5.
go back to reference Urokinase Pulmonary Embolism Trial (1970) Phase 1 results: a cooperative study. J Am Med Assoc 214:2163–2172CrossRef Urokinase Pulmonary Embolism Trial (1970) Phase 1 results: a cooperative study. J Am Med Assoc 214:2163–2172CrossRef
6.
go back to reference Goldhaber SZ, Kessler CM, Heit JA, Elliott CG, Friedenberg WR, Heiselman DE, Wilson DB, Parker JA, Bennett D, Feldstein ML et al (1992) Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial. J Am Coll Cardiol 20:24–30CrossRefPubMed Goldhaber SZ, Kessler CM, Heit JA, Elliott CG, Friedenberg WR, Heiselman DE, Wilson DB, Parker JA, Bennett D, Feldstein ML et al (1992) Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial. J Am Coll Cardiol 20:24–30CrossRefPubMed
7.
go back to reference Goldhaber SZ, Haire WD, Feldstein ML, Miller M, Toltzis R, Smith JL, Taveira da Silva AM, Come PC, Lee RT, Parker JA et al (1993) Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 341(8844):507–511CrossRefPubMed Goldhaber SZ, Haire WD, Feldstein ML, Miller M, Toltzis R, Smith JL, Taveira da Silva AM, Come PC, Lee RT, Parker JA et al (1993) Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 341(8844):507–511CrossRefPubMed
8.
go back to reference Goldhaber SZ (2001) Thrombolysis in pulmonary embolism: a large-scale clinical trial is overdue. Circulation 104:2876–2878PubMed Goldhaber SZ (2001) Thrombolysis in pulmonary embolism: a large-scale clinical trial is overdue. Circulation 104:2876–2878PubMed
10.
go back to reference Dalla-Volta S, Palla A, Santolicandro A, Giuntini C, Pengo V, Visioli O, Zonzin P, Zanuttini D, Barbaresi F, Agnelli G et al (1992) PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J Am Coll Cardiol 20:520–526CrossRefPubMed Dalla-Volta S, Palla A, Santolicandro A, Giuntini C, Pengo V, Visioli O, Zonzin P, Zanuttini D, Barbaresi F, Agnelli G et al (1992) PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J Am Coll Cardiol 20:520–526CrossRefPubMed
11.
12.
go back to reference Kucher N, Boekstegers P, Müller OJ, Kupatt C, Beyer-Westendorf J, Heitzer T, Tebbe U, Horstkotte J, Müller R, Blessing E, Greif M, Lange P, Hoffmann RT, Werth S, Barmeyer A, Härtel D, Grünwald H, Empen K, Baumgartner I (2014) Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation 129:479–486CrossRefPubMed Kucher N, Boekstegers P, Müller OJ, Kupatt C, Beyer-Westendorf J, Heitzer T, Tebbe U, Horstkotte J, Müller R, Blessing E, Greif M, Lange P, Hoffmann RT, Werth S, Barmeyer A, Härtel D, Grünwald H, Empen K, Baumgartner I (2014) Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation 129:479–486CrossRefPubMed
13.
go back to reference Liang NL, Avgerinos ED, Marone LK, Singh MJ, Makaroun MS, Chaer RA (2016) Comparative outcomes of ultrasound-assisted thrombolysis and standard catheter-directed thrombolysis in the treatment of acute pulmonary embolism. Vasc Endovascular Surg 50:405–410CrossRefPubMed Liang NL, Avgerinos ED, Marone LK, Singh MJ, Makaroun MS, Chaer RA (2016) Comparative outcomes of ultrasound-assisted thrombolysis and standard catheter-directed thrombolysis in the treatment of acute pulmonary embolism. Vasc Endovascular Surg 50:405–410CrossRefPubMed
14.
go back to reference Meyer G, Vicaut E, Danays T, Agnelli G, Becattini C, Beyer-Westendorf J, Bluhmki E, Bouvaist H, Brenner B, Couturaud F, Dellas C, Empen K, Franca A, Galiè N, Geibel A, Goldhaber SZ, Jimenez D, Kozak M, Kupatt C, Kucher N, Lang IM, Lankeit M, Meneveau N, Pacouret G, Palazzini M, Petris A, Pruszczyk P, Rugolotto M, Salvi A, Schellong S, Sebbane M, Sobkowicz B, Stefanovic BS, Thiele H, Torbicki A, Verschuren F, Konstantinides SV, PEITHO Investigators (2014) Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 370:1402–1411CrossRefPubMed Meyer G, Vicaut E, Danays T, Agnelli G, Becattini C, Beyer-Westendorf J, Bluhmki E, Bouvaist H, Brenner B, Couturaud F, Dellas C, Empen K, Franca A, Galiè N, Geibel A, Goldhaber SZ, Jimenez D, Kozak M, Kupatt C, Kucher N, Lang IM, Lankeit M, Meneveau N, Pacouret G, Palazzini M, Petris A, Pruszczyk P, Rugolotto M, Salvi A, Schellong S, Sebbane M, Sobkowicz B, Stefanovic BS, Thiele H, Torbicki A, Verschuren F, Konstantinides SV, PEITHO Investigators (2014) Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 370:1402–1411CrossRefPubMed
15.
go back to reference Stein PD, Matta F (2012) Thrombolytic therapy in unstable patients with acute pulmonary embolism: saves lives but underused. Am J Med 125:465–470CrossRefPubMed Stein PD, Matta F (2012) Thrombolytic therapy in unstable patients with acute pulmonary embolism: saves lives but underused. Am J Med 125:465–470CrossRefPubMed
16.
go back to reference Fransen PS, Berkhemer OA, Lingsma HF, Beumer D, van den Berg LA, Yoo AJ, Schonewille WJ, Vos JA, Nederkoorn PJ, Wermer MJ, van Walderveen MA, Staals J, Hofmeijer J, van Oostayen JA, Lycklama À Nijeholt GJ, Boiten J, Brouwer PA, Emmer BJ, de Bruijn SF, van Dijk LC, Kappelle LJ, Lo RH, van Dijk EJ, de Vries J, de Kort PL, van den Berg JS, van Hasselt BA, Aerden LA, Dallinga RJ, Visser MC, Bot JC, Vroomen PC, Eshghi O, Schreuder TH, Heijboer RJ, Keizer K, Tielbeek AV, den Hertog HM, Gerrits DG, van den Berg-Vos RM, Karas GB, Steyerberg EW, Flach HZ, Marquering HA, Sprengers ME, Jenniskens SF, Beenen LF, van den Berg R, Koudstaal PJ, van Zwam WH, Roos YB, van Oostenbrugge RJ, Majoie CB, van der Lugt A, Dippel DW; Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands Investigators (2016) Time to reperfusion and treatment effect for acute ischemic stroke: a randomized clinical trial. J Am Med Assoc Neurol 73:190–196 Fransen PS, Berkhemer OA, Lingsma HF, Beumer D, van den Berg LA, Yoo AJ, Schonewille WJ, Vos JA, Nederkoorn PJ, Wermer MJ, van Walderveen MA, Staals J, Hofmeijer J, van Oostayen JA, Lycklama À Nijeholt GJ, Boiten J, Brouwer PA, Emmer BJ, de Bruijn SF, van Dijk LC, Kappelle LJ, Lo RH, van Dijk EJ, de Vries J, de Kort PL, van den Berg JS, van Hasselt BA, Aerden LA, Dallinga RJ, Visser MC, Bot JC, Vroomen PC, Eshghi O, Schreuder TH, Heijboer RJ, Keizer K, Tielbeek AV, den Hertog HM, Gerrits DG, van den Berg-Vos RM, Karas GB, Steyerberg EW, Flach HZ, Marquering HA, Sprengers ME, Jenniskens SF, Beenen LF, van den Berg R, Koudstaal PJ, van Zwam WH, Roos YB, van Oostenbrugge RJ, Majoie CB, van der Lugt A, Dippel DW; Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands Investigators (2016) Time to reperfusion and treatment effect for acute ischemic stroke: a randomized clinical trial. J Am Med Assoc Neurol 73:190–196
17.
go back to reference Zuin M, Kuo WT, Rigatelli G, Daggubati R, Vassiliev D, Roncon L (2016) Catheter-directed therapy as a first-line treatment strategy in hemodynamically unstable patients with acute pulmonary embolism: yes or no?. Int J Cardiol 225:14–15CrossRefPubMed Zuin M, Kuo WT, Rigatelli G, Daggubati R, Vassiliev D, Roncon L (2016) Catheter-directed therapy as a first-line treatment strategy in hemodynamically unstable patients with acute pulmonary embolism: yes or no?. Int J Cardiol 225:14–15CrossRefPubMed
18.
go back to reference Zuin M, Rigatelli G, Roncon L (2016) Rheolytic thrombectomy in patient with acute pulmonary embolism, heparin-induced thrombocytopenia and recent stoke. When percutaneous treatment is the only therapeutic alternative. Perfusion. doi:10.1177/0267659116646845 Zuin M, Rigatelli G, Roncon L (2016) Rheolytic thrombectomy in patient with acute pulmonary embolism, heparin-induced thrombocytopenia and recent stoke. When percutaneous treatment is the only therapeutic alternative. Perfusion. doi:10.​1177/​0267659116646845​
19.
go back to reference Zuin M, Rigatelli G, Ferraresi S, Zonzin P, Roncon L (2016) Acute pulmonary embolism after post-traumatic spinal epidural hematoma: use of catheter-direct treatment. Cardiovasc Revasc Med. doi:10.1016/j.carrev.2016.09.008 Zuin M, Rigatelli G, Ferraresi S, Zonzin P, Roncon L (2016) Acute pulmonary embolism after post-traumatic spinal epidural hematoma: use of catheter-direct treatment. Cardiovasc Revasc Med. doi:10.​1016/​j.​carrev.​2016.​09.​008
20.
go back to reference Roncon L, Casazza F, Zuin M, Zonzin P, Galli M, Enea I (2016) Percutaneous treatment of pulmonary embolism: diffusion and use of the technique in Italian interventional cardiology centers. Results of the PETER survey. G Ital Cardiol (Rome) 17:268–272 Roncon L, Casazza F, Zuin M, Zonzin P, Galli M, Enea I (2016) Percutaneous treatment of pulmonary embolism: diffusion and use of the technique in Italian interventional cardiology centers. Results of the PETER survey. G Ital Cardiol (Rome) 17:268–272
21.
go back to reference Provias T, Dudzinski DM, Jaff MR, Rosenfield K, Channick R, Baker J, Weinberg I, Donaldson C, Narayan R, Rassi AN, Kabrhel C (2014) The Massachusetts general hospital pulmonary embolism response team (MGH PERT): creation of a multidisciplinary program to improve care of patients with massive and submassive pulmonary embolism. Hosp Pract (1995) 42:31–37CrossRef Provias T, Dudzinski DM, Jaff MR, Rosenfield K, Channick R, Baker J, Weinberg I, Donaldson C, Narayan R, Rassi AN, Kabrhel C (2014) The Massachusetts general hospital pulmonary embolism response team (MGH PERT): creation of a multidisciplinary program to improve care of patients with massive and submassive pulmonary embolism. Hosp Pract (1995) 42:31–37CrossRef
22.
go back to reference Kabrhel C, Jaff MR, Channick RN, Baker JN, Rosenfield K (2013) A multidisciplinary pulmonary embolism response team. Chest 144:1738–1739CrossRefPubMed Kabrhel C, Jaff MR, Channick RN, Baker JN, Rosenfield K (2013) A multidisciplinary pulmonary embolism response team. Chest 144:1738–1739CrossRefPubMed
23.
go back to reference Dudzinski DM, Piazza G (2016) Multidisciplinary pulmonary embolism response teams. Circulation 133:98–103CrossRefPubMed Dudzinski DM, Piazza G (2016) Multidisciplinary pulmonary embolism response teams. Circulation 133:98–103CrossRefPubMed
24.
go back to reference Goodman SG, Menon V, Cannon CP, Steg G, Ohman EM, Harrington RA (2008) American College of Chest Physicians Acute ST-segment elevation myocardial infarction: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133:708S–775SCrossRefPubMed Goodman SG, Menon V, Cannon CP, Steg G, Ohman EM, Harrington RA (2008) American College of Chest Physicians Acute ST-segment elevation myocardial infarction: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133:708S–775SCrossRefPubMed
Metadata
Title
Systemic thrombolysis in acute pulmonary embolism: also a matter of “time”
Authors
Marco Zuin
Loris Roncon
Publication date
01-02-2017
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 2/2017
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-016-1444-2

Other articles of this Issue 2/2017

Journal of Thrombosis and Thrombolysis 2/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.